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In a multivalent approach to discover new antimicrobial substance, a total of 160 Bacilli were isolated 
from termitarium soil, characterized on the basis of their morphological and physiological characters and 
screened for their antimicrobial activity by agar well diffusion method against certain drug resistant 
pathogenic bacteria such as Staphylococcus aureus, Methicillin resistant Staphylococcus aureus and com-
mon food contaminating bacteria Listeria monocytogenes. After preliminary screening, sixteen isolates 
showed inhibitory activity against test pathogens. Among them Bacillus isolate TSH58 exhibited maxi-
mum inhibitory activity against MRSA, Staphylococcus aureus and Listeria monocytogenes. Based on 
morphological, physiological, biochemical and 16S rDNA characteristics isolate TSH58 was identified as 
a member of the Bacillus cereus species group. Various nutrient sources and culture conditions were 
optimized, the partially purified antimicrobial metabolite was subjected to various treatments such as 
heat, pH and proteolytic enzymes. Complete loss in the activity observed when the crude metabolite was 
treated with proteolytic enzymes suggesting its proteinaceous nature and termed as bacteriocin like 
inhibitory substance (BLIS). Minimal inhibitory concentration of the partially purified bacteriocin deter-
mined by microtiter plate assay was 80 µg/ml for MRSA and 40 µg/ml for L. monocytogenes. Tricine SDS 
PAGE analysis revealed that the partially purified bacteriocin produced by the Bacillus strain TSH58 had 
an apparent molecular weight of about 4.0 KDa.
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INTRODUCTION
Increasing drug resistance to antibiotics in bacteria continue to be a major health 
problem worldwide. The current known antibiotics and possible derivatives sooner or 
later lose their efficiency [8]. Treatments are urgently required for the abatement of 
the growing number of infections caused by antibiotic-resistant bacteria. Methicillin 
resistant Staphylococcus aureus (MRSA) is among the major one that have also 
acquired resistance not only to β-lactam antibiotics, but also to flouroquinolones, 
chloramphenicol, clindamycin, tetracycline, and aminoglycosides and more recently 
to vancomycin and teicoplanin around the world [30]. Therefore, urgent research for 
new antimicrobial agents to prevent and treat MRSA infection is needed.
* Corresponding authors; e-mail addresses: maheshwaridk@gmail.com; vbiotech04@gmail.com
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Bacillus spp. are widely distributed in nature and play an important role in inhibit-
ing pathogenic bacteria by producing broad spectrum antimicrobial compounds, i.e. 
bacteriocins. These compounds exhibit strong antimicrobial activities and enable the 
bacterium to survive in its natural environment [29]. Bacteriocins exhibit bactericidal 
activity towards species that are often closely related to the producer bacteria and 
might warrant serious consideration as alternatives to traditional antibiotics [12]. 
They have a narrow or broad spectrum of activity and exhibit significant potency 
against bacteria, including antibiotic resistant strains [9, 24]. Bacteriocins can be used 
in the treatment of multidrug resistant human pathogens. One example is a bacteri-
ocin produced by Enterococcus faecium has shown to inhibit 29 different strains of 
vancomycin resistant of enterococci [28]. In addition, synergistic effect of bacterioc-
ins enhance the efficacy of antibiotics and reduce the animal cell toxicity [17]. On the 
other hand, bacteriocin such as Nisin A produced by Lactic acid bacteria (LAB) is 
used as food preservative in over 50 countries [2].
Termitarium or termite mound or nest is an unexplored ecological niche as far as 
the presence of bacilli is concerned. Being rich in partially digested food materials 
and faecal matter of termites, enriched with minerals and other organic constituents 
provide existence of a huge diversity of microorganisms [15]. Therefore, search for 
potent antimicrobial compounds producing bacilli was made that can combat drug 
resistant bacterial pathogens such as methicillin resistant Staphylococcus aureus 
(MRSA). 
MATERIALS AND METHODS
Isolation of aerobic endospore forming bacilli
Termitarium soil samples were collected from Haridwar district (29°58’N latitude 
and 78°14’E longitude), Uttarakhand in a sterile polythene bag and transported to the 
laboratory. For the isolation of aerobic endospore forming bacilli 10 g soil sample 
was mixed with 90 ml of sterile distilled water and placed in a water bath at 80 °C for 
10 min to kill the vegetative cells [10]. A serial 10-fold dilution was then prepared in 
sterile distilled water up to 10–5. Then, 100 µl of each dilution was spread on nutrient 
agar and Bacillus agar plates (Hi-Media Laboratories, India) and incubated at 30 °C 
for 24 to 48 h. The morphologically distinct colonies were picked and sub-cultured 
on nutrient agar (NA). All bacterial isolates were preliminary characterized according 
to Bergey’s manual of determinative bacteriology [11]. 
Test organisms
Methicillin resistant Staphylococcus aureus isolated from clinical specimen was pro-
cured from PGIMER Dr. Ram Manohar Lohia Hospital, New Delhi, India. 
Staphylococcus aureus ATCC 25923, and Listeria monocytogenes MTCC 657 were 
obtained from local culture collrection, Haridwar, India and used as test pathogens.
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Antimicrobial activity of the isolates
Bacterial isolates were grown in nutrient broth (NB) medium at 30 °C for 48 h. The 
broth was centrifuged at 10,000 rpm for 20 min to sediment the cells and crude super-
natant was tested against Staphylococcus aureus ATCC 25923, methicillin resistant 
Staphylococcus aureus and Listeria monocytogenes MTCC 657 by agar well diffu-
sion method. In brief, Mueller Hinton agar plates seeded with test pathogen 106 CFU/
ml were taken. Wells of 6.0 mm diameter were made using sterilized steel borer. 
Then, 100 µl culture supernatant of isolated bacteria were added to the well and the 
plates were incubated at 37 °C for 18–24 h. Inhibition zones were recorded and bac-
teria showing maximum inhibition were selected for further study [31].
Molecular characterization and phylogenetic analysis
To determine the identity of the selected Bacillus strain TSH58, it was subjected to 
genomic DNA extraction and amplification of 16S rDNA [23]. The extracted DNA 
was dissolved in 20 μl TE buffer and used as the template for the PCR reactions. PCR 
amplifications were performed in a total volume of 50 μl by mixing 100 ng of the 
template DNA with 2.5 mM concentrations of each deoxynucleotide triphosphate and 
0.3 mM of each universal primer of Bac27F (5′-AGAGTTTGATCMTGGCTCAG 
-3′) and Univ1492R (5′-CGGTTACCTTGTTACGACTT-3′) described by Jiang et al. 
[13]. The thermocycling profile was carried out with an initial denaturation at 95 °C 
(2 min) followed by  denaturation at 95 °C (30 sec), annealing at 52 °C (30 sec), 
extension at 72 °C (2 min), and a final extension at 72 °C (15 min) in an Eppendorf 
Gradient thermocycler. The PCR amplified rDNA was purified by using the Quick 
PCR purification kit (Bangalore Genie, India). The amplified DNA sequences were 
aligned using multiple sequence alignment programs and phylogenetic analysis was 
performed using mega 7 software [14].
Optimization of media and culture conditions
For the production of the maximum amount of antimicrobial compound, various carbon 
sources, nitrogen sources and physiological parameters such as temperature, incubation 
period and pH of the fermentation conditions were optimized and the antimicrobial 
activity of the test supernatant was determined as outlined by Risoen et al. [20].
Titration of antibiotic units in culture supernatant
The titre of the antibiotic units in the culture supernatant was carried out by twofold 
serial dilution of supernatant in normal saline up to 12× times. A 50 µl of each dilu-
tion was placed into wells made on Mueller-Hinton agar plates seeded with 106 cells 
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of test pathogens. The plates were incubated at 37 °C for 18–24 h and the inhibition 
zones were measured. The antibiotic activity is defined as the highest dilution 
of the supernatant that inhibits the growth of test pathogens in vitro and is expressed 
as activity units AU/ml and was calculated by using the formula given by Batdorj 
et al. [6]. Bacteriocin activity (AU/ml) = (the highest dilution exhibiting inhibition 
zone ×1000)/Volume (µl).
Determination of nature of antimicrobial compound
To determine the nature of antimicrobial compound, the culture supernatant was 
treated with  a final concentration of 1 mg/ml of proteolytic enzymes such as protein-
ase K and trypsin and incubated at 37 °C for 6 h.
Extraction of crude antibacterial protein
The extraction of antibacterial protein was carried out following the method of 
Oscariz et al. [18] with few modifications. The bacterial isolate was grown in 500 ml 
nutrient broth supplemented with 1% glucose at 30 °C for 36 h. The broth was cen-
trifuged at 10,000 rpm for 20 min and the cell free supernatant was filtered through a 
0.22 um bacteriological filter. Solid ammonium sulphate was added up to 60% satura-
tion and kept overnight at 4 °C in a shaking incubator. The mixture was then centri-
fuged at 12,000 rpm for 20 min. The precipitate was collected and re-suspended in 
10 ml of 50 mM sodium phosphate buffer (PBS pH 7.0). The solution was dialyzed 
against the same buffer overnight using dialysis membrane of 3.0 KDa cut off 
(Hi media Labs Pvt. Ltd, India) and crude dialysed metabolite was then extracted 
with butanol (1:2 ratio butanol: sample). Afterwards, the butanol was evaporated and 
the extracted crude metabolite named as bacteriocin like inhibitory substance (BLIS) 
was dissolved in 2.0 ml of PBS and stored at –20 °C. The antimicrobial activity of 
the partially purified BLIS was determined by agar well diffusion method as previ-
ously described, which exhibited inhibition zone of 23 mm for MRSA and 28 mm for 
L. monocytogenes.
Effect of heat, pH and proteolytic enzymes on crude metabolite
To determine the thermal stability, the partially purified BLIS was treated at 50, 60, 
70, 80, 90, 100 and 121 °C for 10 min and antimicrobial activity was determined by 
agar well diffusion method as previously described. To investigate the effect of pH, 
antibacterial activity was measured by adjusting the pH of the BLIS ranging from 3 
to 11 and stored at 4 °C for 4 h. Effect of proteolytic enzymes was determined by 
treating the crude BLIS with final concentration of 1 mg/ml of the enzymes trypsin 
and proteinase K and incubation at 37 °C for 6 h [5].
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Determination of minimal inhibitory concentration (MIC) 
of crude protein
Minimal inhibitory concentration of crude antimicrobial metabolite was determined 
by microtiter plate assay as described by Wu et al. [32] with some modifications. The 
2,3,5 tri phenyl tetrazolium salt at a final concentration of 0.01 percent was added 
as a growth indicator. A sterile 96-well plate was labelled and 200 µl of crude extract 
(10 mg/ml) in PBS) was pipetted into the first well of the plate. To all other wells, 100 
µl of Mueller Hinton broth containing tetrazolium salt was added. Doubling dilution 
was performed using a micro pipette such that each well had 100 µl of the test mate-
rial in descending concentrations. Then, 10 µl of bacterial suspension 5 × 106 cfu/ml 
was added to each well to achieve a concentration of 5 × 105 cfu/ml. Each plate was 
wrapped with aluminium foil to ensure that bacteria did not become dehydrated and 
the MIC was determined as the lowest dilution that inhibited the growth of indicator 
organism. Each plate had a set of controls: a row with a broad-spectrum antibiotic 
gentamicin as a positive control in doubling dilution, a row with all solutions except 
the test compound, and a row with all solutions except the bacterial solution adding 
10 µl of Mueller Hinton broth instead.
Assessment of mode of action
To determine the mode of action of partially purified BLIS a pre-determined concen-
tration of 100 µg/ml and 200 µg/ml were added to mid-logarithmic growth phase 
culture of MRSA in 100 ml nutrient broth. The culture was incubated at 37 °C and 
samples were taken at different time intervals and the optical density was measured 
at 600 nm and number of viable cells (CFU/ml) was measured by the standard plate 
counting method on NAM. Nutrient broth inoculated with MRSA was served as con-
trol [27].
Determination of molecular weight of antimicrobial compound
The molecular mass of bacteriocin produced by B. cereus TSH58 was estimated in a 
Tricine SDS-PAGE system as described by Schagger and Von Jagow [25], using 4% 
acrylamide in the stacking concentration gel and 16% acrylamide in the separation gel. 
After electrophoresis, the gel was cut in two vertical parts. Proteins were visualized 
after staining the first half of the gel with the Silver Stain Plus Kit (Bio-Rad, Richmond, 
CA, USA). The other part was assayed for antimicrobial activity, according to Oscariz 
et al. [19]. Briefly, the gel was rinsed with distilled water (1 h initial rinsed followed 
by two washes of 5 min), and overlaid with 20 ml of soft (0.8%) nutrient agar seeded 
with 106 CFU/ml of indicator strain MRSA. After incubation at 37 °C for 24 h, the gel 
was examined for the presence of an inhibitory zone. Molecular mass markers for 
peptides (3B Black Biotech India Ltd.) were used for mass standards. 
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RESULTS
Based on the morphological, physiological and biochemical characterization, a total 
of 160 Bacillus strains were isolated from termitarium soil (36.5% sand, 62% clay, 
total organic C 0.62% and pH 7.4) of the Haridwar district (29°58’N latitude and 
78°14’E longitude), Uttarakhand, India. All 160 isolates were screened for their anti-
microbial activity against MRSA, Staphylococcus aureus ATCC 25923 and Listeria 
monocytogenes MTCC 657. Sixteen isolates showed antibacterial activity against at 
least one of the three test pathogens. Isolate TSH58 showed maximum activity 
against all the three test pathogens and selected for further study. The 16SrRNA gene 
sequences of the isolate TSH58 were aligned using NCBI database and phylogenetic 
tree was constructed using Mega 7 (Fig. 1). On the basis of 16SrRNA gene sequenc-
ing and biochemical characterization, the isolate TSH58 was identified as a member 
of the Bacillus cereus species group and the gene sequence of the isolate TSH58 was 
submitted in the NCBI Gene Bank with accession no. KX344724.
Several nutrient sources and physiological parameters optimized for the maximum 
production of antimicrobial metabolite production and peptone and glucose were 
found to be most suitable (data not shown). The growth analysis of the isolate TSH58 
along with studies of antimicrobial metabolite production indicated that production 
of antimicrobial compound started after 16 h of incubation (early stationary phase) 
Fig. 1. Neighbour-joining phylogenetic tree based on 16S rRNA gene sequences, showing the phyloge-
netic relationship of the isolate TSH58 and other members of the genus Bacillus
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Fig. 2. Growth phase dependent production of bacteriocin by B. cereus TSH58. 
Bars representing standard error
Fig. 4. Effect of partially purified bacteriocin on the growth of methicillin resistant Staphylococcus 
aureus. The results are expressed as log CFU/ml counted in the presence of 100 µg/ml and 200 µg/ml of 
bacteriocin. Nutrient broth without bacteriocin was used as control
Fig. 3. Residual activity and stability of bacteriocin at various temperature and pH
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and maximum production was seen between 32 to 36 h of incubation at 30 ± 1 °C by 
maintaining the pH 7.0 when 0.5% peptone and 1% glucose were added as nutrient 
sources (Fig. 2). Complete loss of antimicrobial activity was observed when the cul-
ture supernatant of the isolate B. cereus TSH58 was treated with proteolytic enzymes 
trypsin and proteinase K, indicated the proteinaceous nature of the compound. Thus, 
it may be classified as bacteriocin like inhibitory substance (BLIS) with 1280 AU/ml. 
The stability of the partially purified BLIS was elaborated at various pH and high-
est antimicrobial activity was exhibited at the pH 7.0. The BLIS showed slight change 
in its activity profile between pH 5.0 to 9.0. However, the activity was found sharply 
reduced at pH below 3.0 and above 11.0 (Fig. 3). The antimicrobial substance pro-
duced by B. cereus showed stability during heat treatments. The residual activity of 
BLIS did not exhibit a significant difference from the control. The BLIS produced by 
the isolate TSH58 was considered to be heat stable as the activity persists even after 
heating at 121 °C (Fig. 3).
The MIC analysis of the partially purified BLIS showed L. monocytogenes 
was more sensitive as compared to MRSA. The MIC of the BLIS was determined 
~40 µg/ml in case of L. monocytogenes and ~80 µg/ml for MRSA. To determine 
whether the partially purified BLIS is bacteriostatic or bactericidal, BLIS at a concen-
tration 100 µg/ml (low dose) and 200 µg/ml (high dose) were added to mid-logarith-
mic culture of MRSA. Addition of BLIS resulted in very fast decrease in the viabil-
ity of bacterial cells over a period of 8 h and no growth was observed after 16 h of 
incubation. Whereas the optical density recorded was found constant during the 
incubation period (Fig. 4).
Fig. 5. Tricine SDS PAGE analysis of partially purified bacteriocin from B. cereus TSH58 (A) Silver 
stained gel (M) Peptide molecular weight marker (Lines 1, 2, and 3 are control rows inoculated with buf-
fer only (4) Circle part showing bacteriocin from B. cereus TSH589 (B) Contrast image of bacteriocin 
from B. cereus TSH58
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The partially purified bacteriocin was analyzed by the tricine SDS-PAGE for the 
determination of the molecular weight. One part of the gel was assayed for antimicro-
bial activity using the agar overlaying technique with nutrient soft agar containing 
indicator organisms. A zone of inhibition was observed at the position equivalent to 
a protein band, having a molecular mass of about 4 kDa, formed in the other part of 
the stained SDS-PAGE gel (Fig. 5). From the results obtained through SDS-PAGE, it 
may be concluded that the antibacterial bacteriocin produced by B. cereus TSH58 
was a peptide with a molecular mass of about 4 kDa (Fig. 5). On the basis of its low 
molecular weight and proteinaceous nature, it may be classified as bacteriocin.
DISCUSSION
An increasing number of MRSA infections have become a serious global problem, 
hence, new therapeutic agents are urgently required to overcome this problem [21]. 
Bacteriocins may be used as an alternative to overcome this problem. Although a 
variety of bacteriocins have been discovered, very scanty research has been con-
ducted on their use as therapeutic agents [9]. In this study, a neglected ecological 
habitat was explored from which Bacillus strain TSH58 was isolated, which exhibits 
antimicrobial activity against MRSA and L. monocytogenes. Nutrient broth supple-
mented with 1% glucose exhibited maximum production of bacteriocin as compared 
to other nitrogen sources such as tryptone and casein. From these results, it can be 
estimated that animal peptone and glucose are suitable for bacteriocin production as 
compared to soya peptone. Earlier, the partially purified antimicrobial substance 
extracted from the strain TSH58 completely lost its activity treated with the prepara-
tion of proteolytic enzymes, suggesting its proteinaceous nature and thus classified as 
bacteriocin like inhibitory substance (BLIS). The proteinaceous nature of the BLIS 
was clearly demonstrated by applying denaturing PAGE, which showed that the band 
observable after purification corresponded to the activity observed after incubation of 
the indicator strain with a gel slice containing BLIS. The SDS PAGE analysis 
revealed a clear band of ~4 KDa. Bacillus strains have been reported to produce 
several low molecular weight bacteriocins, i.e. cerein GN105 with mol. wt. 9 KDa 
[16], cerein 7A with mol. wt 3.95 KDa [19], cerein 7B with mol. wt 4.89 KDa [18], 
cerein 8A with mol. wt. 26 KDa [7] and cerein MRX1 with mol. wt. 3.14 [26]. 
Production of antibacterial bacteriocins is common among Bacillus species and most 
of them are active against Gram-positive bacteria. However, quite a few Bacillus spp. 
exhibit killing activity against MRSA [3, 19]. Hence, the BILS isolated in this study 
could be recommended as an alternative to combat drug resistant bacterial pathogens 
such as MRSA. It has an added advantage to the industry if it showed stability to heat 
and pH. The BLIS produced by B. cereus TSH58 was found to be thermostable and 
tolerant to a wide range of pH. The heat and pH stability of bacteriocins has been 
reported previously for the BLIS isolated from B. cereus [20], Bacillus pumilus [40], 
B. coagulans [1] and B. subtilis [32].
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The MIC of the partially purified bacteriocin against MRSA determined by 
micro-titre plate assay was ~80 µg/ml. Therefore, to determine the mode of action 
of the partially purified bacteriocin, one lower dose (100 µg/ml) and one higher 
dose (200 µg/ml) concentration of the partially purified bacteriocin was added to 
mid-logarithmic culture of MRSA. A continuous decline in the viable cell count 
was observed. The optical density of the culture remained constant in the experi-
ment indicated the bactericidal nature of the bacteriocin without cell lysis. The 
bactericidal nature of the bacteriocin was corresponded to concentration and was 
time-dependent which showed decline in the number of viable cells of MRSA, and 
no viable growth was observed after 12 h of incubation when 200 µg/ml of bacte-
riocin was used, and after 16 h when 100 µg/ml of the bacteriocin was used. The 
bactericidal nature of the Bacillus bacteriocins with or without cell lysis has also 
been reported previously [22, 27].
The present study proved that exploration of rare ecological habitats such as termi-
tarium provides a rich source of microrganisms with valuable properties that may 
provide a tool to combat drug resistant pathogen infections via their new drug devel-
opment potential which can provide novel antimicrobial compound to act as a probi-
otic in nature. 
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